Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- FIVE -15.3% (lowers Q2 guidance; CEO steps down; searching for new CEO), ASML -8.1%, SAVE -6.3% (lowers Q2 revenue guidance), HWC -4.9%, OMC -3.4%, JBHT -2.9%, FHN -2.2%, GMAB -2.1% (sales guidance), CFG -2%
Other news:
- ADVM -7.5% (Presents Positive Ixo-vec Clinical Data from the 26-Week Interim Analysis of the LUNA Phase 2 Trial at the 2024 ASRS Annual Meeting)
- LILM -4.8% (reaffirms 2026 target for first customer deliveries; provides additional details)
- ANF -3.3% (to move to S&P MidCap 400 from SmallCap 600)
- DG -2.8% (in sympathy with FIVE guide down)
- J -2.5% (files Form 10 Registration Statement for planned spin-off of Critical Mission Solutions and Cyber & Intelligence Businesses and Merger with Amentum) RLAY -2.1% (Genentech and F. Hoffmann-La Roche terminate collaboration)
- DLTR -2.1% (in sympathy with FIVE guide down)
- ARGX -2.1% (provided investor updates with its 2030 Vision in presentation)
- NOVA -1.5% (Hurricane Beryl's Devastating Impact on Houston Power Grid Reinforces Value of Sunnova Solar + Storage Service for Homeowners)
- USM -1.4% (files $1 bln mixed shelf securities offering)
- OLLI -1.1% (in sympathy with FIVE guide down)
- VALE -1% (reports Q2 production and sales)